Multiple Assemblies exist for SMTL entry 5ev8
Crystal structure of the metallo-beta-lactamase IMP-1 in complex with the bisthiazolidine inhibitor D-CS319; X-RAY DIFFRACTION 2.30 Å

	SMTL ID 5ev8.1 Ligands ZINC ION; (3S,5S,7aR)-5-(sulfanylmethyl)tetrahydro[1,3]thiazolo[4,3-b][1,3]thiazole-3-carboxylic acid Polypeptides Beta-lactamase IMP-1 Oligo-state monomer
	SMTL ID 5ev8.2 Ligands ZINC ION; (3S,5S,7aR)-5-(sulfanylmethyl)tetrahydro[1,3]thiazolo[4,3-b][1,3]thiazole-3-carboxylic acid; 1,2-ETHANEDIOL; DIMETHYL SULFOXIDE Polypeptides Beta-lactamase IMP-1 Oligo-state monomer
	SMTL ID 5ev8.3 Ligands ZINC ION; (3S,5S,7aR)-5-(sulfanylmethyl)tetrahydro[1,3]thiazolo[4,3-b][1,3]thiazole-3-carboxylic acid; 1,2-ETHANEDIOL; DIMETHYL SULFOXIDE; SODIUM ION; CHLORIDE ION Polypeptides Beta-lactamase IMP-1 Oligo-state monomer
	SMTL ID 5ev8.4 Ligands ZINC ION; (3S,5S,7aR)-5-(sulfanylmethyl)tetrahydro[1,3]thiazolo[4,3-b][1,3]thiazole-3-carboxylic acid; 1,2-ETHANEDIOL Polypeptides Beta-lactamase IMP-1 Oligo-state monomer